SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-012934
Filing Date
2018-05-10
Accepted
2018-05-10 16:04:25
Documents
45
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 ALBO-Q1-2018033118 albo-10q_20180331.htm 10-Q 917167
2 EX-31.1 albo-ex311_9.htm EX-31.1 8310
3 EX-31.2 albo-ex312_6.htm EX-31.2 8161
4 EX-32.1 albo-ex321_7.htm EX-32.1 8655
  Complete submission text file 0001564590-18-012934.txt   3312727

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT albo-20180331.xml EX-101.INS 567470
6 XBRL TAXONOMY EXTENSION SCHEMA albo-20180331.xsd EX-101.SCH 32599
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE albo-20180331_cal.xml EX-101.CAL 30269
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE albo-20180331_def.xml EX-101.DEF 80892
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE albo-20180331_lab.xml EX-101.LAB 262630
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE albo-20180331_pre.xml EX-101.PRE 185946
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33451 | Film No.: 18822431
SIC: 2834 Pharmaceutical Preparations